Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies
- PMID: 7692148
- DOI: 10.1097/00005344-199321002-00006
Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies
Abstract
Hypertension is a major contributor to cardiovascular disease, which imparts a threefold increased risk over that of normotensive persons the same age. It accelerates atherogenesis-promoting premature coronary disease, now its most common sequela. The effect of elevated blood pressure on cardiovascular disease morbidity and mortality in general and on coronary disease incidence in particular is independent of the influence of other predisposing atherogenic cofactors but is greatly affected by them. Elevated blood pressure is more often than usual associated with hyperlipidemia, hyperglycemia, hyperuricemia, excessive weight, elevated fibrinogen, and electrocardiogram (ECG) abnormalities, which enhance its impact. Hypertensive coronary candidates usually have an increased low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, impaired glucose tolerance. ECG abnormalities, or a cigarette smoking habit. These coexisting risk factors exert a greater influence than the character of the blood pressure elevation. Those at risk for hypertensive stroke have left ventricular hypertrophy (LVH), atrial fibrillation, cardiac failure, coronary disease, diabetes, or a cigarette habit. Cardiovascular risk ratios for hypertension diminish with advancing age, but this is offset by a higher absolute risk, making hypertension an important precursor of cardiovascular disease in the elderly.
Similar articles
-
Potency of vascular risk factors as the basis for antihypertensive therapy.Eur Heart J. 1992 Dec;13 Suppl G:34-42. doi: 10.1093/eurheartj/13.suppl_g.34. Eur Heart J. 1992. PMID: 1486903
-
Hypertension. Relationship with other risk factors.Drugs. 1986;31 Suppl 1:1-11. doi: 10.2165/00003495-198600311-00004. Drugs. 1986. PMID: 3720567
-
Hypertension, hypertrophy, and the occurrence of cardiovascular disease.Am J Med Sci. 1991 Oct;302(4):199-204. doi: 10.1097/00000441-199110000-00001. Am J Med Sci. 1991. PMID: 1833977
-
Influence of multiple risk factors on the hazard of hypertension.J Cardiovasc Pharmacol. 1990;16 Suppl 5:S53-7. J Cardiovasc Pharmacol. 1990. PMID: 11527137 Review.
-
[Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension].Vutr Boles. 1985;24(6):39-47. Vutr Boles. 1985. PMID: 3913145 Review. Bulgarian. No abstract available.
Cited by
-
Clinical variables associated with major adverse cardiac events following radical cystectomy.BJUI Compass. 2023 Dec 5;5(4):480-488. doi: 10.1002/bco2.315. eCollection 2024 Apr. BJUI Compass. 2023. PMID: 38633835 Free PMC article.
-
Rescue Operations Lead to Increased Cardiovascular Stress in HEMS Crew Members: A Prospective Pilot Study of a German HEMS Cohort.J Clin Med. 2021 Apr 9;10(8):1602. doi: 10.3390/jcm10081602. J Clin Med. 2021. PMID: 33918944 Free PMC article.
-
Urinary albumin as a marker of future blood pressure and hypertension in the general population.Medicine (Baltimore). 2015 Feb;94(6):e511. doi: 10.1097/MD.0000000000000511. Medicine (Baltimore). 2015. PMID: 25674745 Free PMC article.
-
Predictors of Co-occurring Cardiovascular and Gastrointestinal Disorders among Elderly with Osteoarthritis.Osteoarthr Cartil Open. 2021 Mar 11;3(2):100148. doi: 10.1016/j.ocarto.2021.100148. eCollection 2021 Jun. Osteoarthr Cartil Open. 2021. PMID: 36474979 Free PMC article.
-
A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension.Br J Clin Pharmacol. 2000 Sep;50(3):215-20. doi: 10.1046/j.1365-2125.2000.00260.x. Br J Clin Pharmacol. 2000. PMID: 10971305 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical